| Dan Siskind | From the Metro South Addiction and Mental Health Service, Brisbane, Australia (Siskind); the University of Queensland, School of Clinical Medicine, Brisbane, Australia (Siskind, Myles); the Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada (Honer); the University of Adelaide, School of Medicine, Adelaide, Australia (Clark, Kane); the The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA (Correll, Kane); the Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA (Correll); Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany (Correll); the Department of Psychiatry, Psychotherapy and Psychosomatics of the University Augsburg, Augsburg, Germany (Hassan); the Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK (Howes, MacCabe); the MRC London Institute of Medical Sciences, Hammersmith Hospital, London, UK (Howes); the Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK (Howes); the Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA (Kelly); the Bronx Westchester Medical Group, New York, NY, USA (Laitman); the North Region & Department of Psychosis, Institute of Mental Health, Singapore (Lee); the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore (Lee); the Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen (Nielsen); the Mental Health Service Noord-Holland-Noord, Alkmaar, The Netherlands (Schulte); the South London and Maudsley NHS Foundation Trust, Pharmacy Department, Maudsley Hospital, London, UK (Taylor); the University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Bordeaux, France (Verdoux); the Menzies Health Institute Queensland, Griffith University, Brisbane, Australia (Wheeler); the MGH Schizophrenia Clinical and Research Program, Massachusetts General Hospital, Boston, MA, USA (Freudenreich); and the Harvard Medical School, Boston, MA, USA (Freudenreich).
| 000C80
| From the Metro South Addiction and Mental Health Service, Brisbane, Australia (Siskind); the University of Queensland, School of Clinical Medicine, Brisbane, Australia (Siskind, Myles); the Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada (Honer); the University of Adelaide, School of Medicine, Adelaide, Australia (Clark, Kane); the The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA (Correll, Kane); the Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA (Correll); the Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany (Correll); the Department of Psychiatry, Psychotherapy and Psychosomatics of the University Augsburg, Augsburg, Germany (Hasan); the Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK (Howes); the MRC London Institute of Medical Sciences, Hammersmith Hospital, London, UK (Howes, MacCabe); the Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK (Howes); the Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA (Kelly); the Bronx Westchester Medical Group, New York, USA (Laitman); the North Region & Department of Psychosis, Institute of Mental Health, Singapore (Lee); the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore (Lee); the Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark (Nielsen); the Mental Health Service Noord-Holland-Noord, Alkmaar, The Netherlands (Schulte); the South London and Maudsley NHS Foundation Trust, Pharmacy Department, Maudsley Hospital, London, UK (Taylor); the University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Bordeaux, France (Verdoux); the Menzies Health Institute Queensland, Griffith University, Brisbane, Australia (Wheeler); the MGH Schizophrenia Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA (Freudenreich); and the Harvard Medical School, Boston, Massachusetts, USA (Freudenreich).
| 000383
| From the Metro South Addiction and Mental Health
Service, Brisbane, Australia (Siskind); the University of Queensland,
School of Clinical Medicine, Brisbane, Australia (Siskind, Myles); the
Department of Psychiatry, University of British Columbia, Vancouver,
BC, Canada (Honer); the University of Adelaide, School of Medicine,
Adelaide, Australia (Clark, Kane); the The Zucker Hillside Hospital,
Department of Psychiatry, Northwell Health, Glen Oaks, NY,
USA (Correll, Kane); the Zucker School of Medicine at Hofstra/
Northwell, Department of Psychiatry and Molecular Medicine,
Hempstead, NY, USA (Correll); Charité Universitätsmedizin Berlin,
Department of Child and Adolescent Psychiatry, Berlin, Germany
(Correll); the Department of Psychiatry, Psychotherapy and Psychosomatics
of the University Augsburg, Augsburg, Germany (Hassan);
the Institute of Psychiatry, Psychology & Neuroscience, King’s College
London, London, UK (Howes, MacCabe); the MRC London Institute
of Medical Sciences, Hammersmith Hospital, London, UK
(Howes); the Institute of Clinical Sciences (ICS), Faculty of Medicine,
Imperial College London, London, UK (Howes); the Maryland
Psychiatric
Research Center, University of Maryland School of Medicine,
Baltimore, MD, USA (Kelly); the Bronx Westchester Medical
Group, New York, NY, USA (Laitman); the North Region & Department
of Psychosis, Institute of Mental Health, Singapore (Lee); the
Lee Kong Chian School of Medicine, Nanyang Technological University,
Singapore (Lee); the Mental Health Centre Copenhagen, Copenhagen
University Hospital, Copenhagen (Nielsen); the Mental Health
Service Noord-Holland-
Noord, Alkmaar, The Netherlands (Schulte);
the South London and Maudsley NHS Foundation Trust, Pharmacy
Department, Maudsley Hospital, London, UK (Taylor); the University
of Bordeaux, INSERM, Bordeaux Population Health Research
Center, Bordeaux, France (Verdoux); the Menzies Health Institute
Queensland, Griffith University, Brisbane, Australia (Wheeler); the
MGH Schizophrenia Clinical and Research Program, Massachusetts
General Hospital, Boston, MA, USA (Freudenreich); and the Harvard
Medical School, Boston, MA, USA (Freudenreich)
| 000D44
| Metro South Mental Health and Addiction Services, Brisbane, Australia d.siskind@uq.edu.au.
| 000A67
| Metro South Public Health Unit, Coopers Plains, Australia.
| 000A67
| Princess Alexandra Hospital, Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia.
| 000949
| Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Australia.
| 000A67
| School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.
| 000949
|
|
|---|
